LOS ANGELES,gaslight cafe new york CA / ACCESSWIRE / April 2, 2020 /

The Schall Law Firm

, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Inovio Pharmaceuticals, Inc. ("Inovio" or "the Company") (NASDAQ:

INO

) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between February 14, 2020 and March 9, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before May 11, 2020.

If you are a shareholder who suffered a loss,

click here to participate

.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at

www.schallfirm.com

, or by email at

[email protected]

.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Inovio made misleading statements about its purported development of a vaccine for COVID-19 coronavirus. The materially misleading statements artificially inflated the Company's share price, resulting in investor losses. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Inovio, investors suffered damages,

Join the case

to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm

Brian Schall, Esq.

310-301-3335

[email protected]

www.schallfirm.com

SOURCE:

The Schall Law Firm

View source version on accesswire.com:

https://www.accesswire.com/583652/IMPORTANT-INVESTOR-NOTICE-The-Schall-Law-Firm-Announces-the-Filing-of-a-Class-Action-Lawsuit-Against-Inovio-Pharmaceuticals-Inc-and-Encourages-Investors-with-Losses-in-Excess-of-500000-to-Contact-the-Firm

View comments